These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 938021

  • 41. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
    Torres A, Aguirre M, Ales JM.
    Rev Clin Esp; 1979 Nov 30; 155(4):249-52. PubMed ID: 542674
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates.
    Jones RN, Fuchs PC, Gavan TL, Gerlach EH, Barry AL, Thornsberry C.
    Antimicrob Agents Chemother; 1977 Jul 30; 12(1):47-50. PubMed ID: 883818
    [Abstract] [Full Text] [Related]

  • 45. [In vitro activity of cefotaxime against enterobacteriaceae. Comparison with cephalothin, cefazolin, cefamandole, cefoxitin and cefuroxime on 117 strains isolated from neutropenic patients (author's transl)].
    Tancrede C, Mariel C, Chaigneau H, Eveno J.
    Nouv Presse Med; 1981 Feb 26; 10(8):545-7. PubMed ID: 6259589
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Comparative in vitro activity of newer cephalosporins against anaerobic bacteria.
    Chow AW, Bednorz D.
    Antimicrob Agents Chemother; 1978 Nov 26; 14(5):668-71. PubMed ID: 727759
    [Abstract] [Full Text] [Related]

  • 49. A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin.
    du T Naudé W, van den Ende J, Botha P, Forder A, Hyland J, de Klerk HC, Neiteler BF, Koornhof HJ, Robinson R, Robins-Browne R, Block C, Appelbaum PC, Africa CW, van Rensburg AJ, Jooste PJ, Crewe-Browne H, Fernandez A.
    S Afr Med J; 1977 Nov 05; 52(20):798-800. PubMed ID: 305120
    [Abstract] [Full Text] [Related]

  • 50. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD.
    J Antibiot (Tokyo); 1977 Apr 05; 30(4):326-9. PubMed ID: 324961
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates.
    Trabulsi LR, Pereira da Silva Almada N, Marques LR.
    Clin Ther; 1980 Apr 05; 3(Spec Issue):145-8. PubMed ID: 6446390
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The in vitro activity of cefamandole against 3312 bacterial isolates. A Norwegian multicentre study.
    Digranes A, Bjorvatn B.
    NIPH Ann; 1980 Dec 05; 3(2):141-7. PubMed ID: 7219840
    [Abstract] [Full Text] [Related]

  • 55. Cefamandole: antimicrobial activity in vitro of a new cephalosporin.
    Meyers BR, Leng B, Hirschman SZ.
    Antimicrob Agents Chemother; 1975 Dec 05; 8(6):737-41. PubMed ID: 1044248
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT, Andriole VT.
    Yale J Biol Med; 1980 Dec 05; 53(2):149-59. PubMed ID: 6446810
    [Abstract] [Full Text] [Related]

  • 60. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
    Menzies RE, Cornere BM, MacCulloch D.
    Antimicrob Agents Chemother; 1987 Jan 05; 31(1):42-5. PubMed ID: 3646002
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.